July 10, 2017 - By Adrian Erickson
Analysts expect West Pharmaceutical Services Inc. (NYSE:WST) to report $0.65 EPS on July, 27.They anticipate $0.06 EPS change or 10.17% from last quarter’s $0.59 EPS. WST’s profit would be $48.80 million giving it 36.32 P/E if the $0.65 EPS is correct. After having $0.60 EPS previously, West Pharmaceutical Services Inc.’s analysts see 8.33% EPS growth. About 54,199 shares traded. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since July 10, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.
Hostess Brands Class A (NASDAQ:TWNK) had an increase of 13.24% in short interest. TWNK’s SI was 10.41 million shares in July as released by FINRA. Its up 13.24% from 9.19M shares previously. With 1.16 million avg volume, 9 days are for Hostess Brands Class A (NASDAQ:TWNK)’s short sellers to cover TWNK’s short positions. The SI to Hostess Brands Class A’s float is 13.2%. About 324,206 shares traded. Hostess Brands, Inc. (NASDAQ:TWNK) has risen 69.90% since July 10, 2016 and is uptrending. It has outperformed by 53.20% the S&P500.
Among 3 analysts covering West Pharmaceutical Services (NYSE:WST), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. West Pharmaceutical Services had 7 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, August 4 by Zacks. The rating was initiated by Wells Fargo on Tuesday, March 22 with “Outperform”. The rating was initiated by Janney Capital on Friday, January 8 with “Buy”. Wells Fargo downgraded the stock to “Market Perform” rating in Wednesday, September 21 report. The firm has “Outperform” rating by Wells Fargo given on Friday, October 28. The stock has “Hold” rating by Jefferies on Tuesday, June 6. The firm earned “Hold” rating on Thursday, June 29 by Jefferies.
Since May 2, 2017, it had 0 buys, and 2 sales for $5.63 million activity. 54,996 shares were sold by FEDERICI WILLIAM J, worth $5.25 million. The insider Malone Daniel sold $384,816.
West Pharmaceutical Services, Inc. is a maker of packaging components and delivery systems for injectable drugs and healthcare products. The company has market cap of $7.09 billion. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. It has a 38.91 P/E ratio. The Company’s divisions include Proprietary Products and Contract-Manufactured Products.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.